ESPOSITO, Elisabetta
 Distribuzione geografica
Continente #
NA - Nord America 18.830
AS - Asia 10.388
EU - Europa 7.207
SA - Sud America 1.671
Continente sconosciuto - Info sul continente non disponibili 388
AF - Africa 225
OC - Oceania 14
Totale 38.723
Nazione #
US - Stati Uniti d'America 18.389
SG - Singapore 4.001
CN - Cina 2.454
FI - Finlandia 2.242
BR - Brasile 1.312
IT - Italia 1.298
VN - Vietnam 1.059
UA - Ucraina 886
HK - Hong Kong 835
DE - Germania 799
GB - Regno Unito 569
TR - Turchia 491
FR - Francia 321
JP - Giappone 304
IN - India 300
BD - Bangladesh 261
SE - Svezia 257
RU - Federazione Russa 232
CA - Canada 191
PL - Polonia 169
MX - Messico 164
ID - Indonesia 133
AR - Argentina 120
IQ - Iraq 108
ZA - Sudafrica 86
NL - Olanda 77
AT - Austria 65
CO - Colombia 63
EC - Ecuador 58
PK - Pakistan 56
ES - Italia 48
LT - Lituania 43
BE - Belgio 42
TH - Thailandia 37
SA - Arabia Saudita 34
VE - Venezuela 33
PH - Filippine 32
KR - Corea 31
MY - Malesia 30
CL - Cile 29
MA - Marocco 25
RO - Romania 25
UZ - Uzbekistan 25
JO - Giordania 23
IR - Iran 22
IL - Israele 20
NP - Nepal 20
AE - Emirati Arabi Uniti 19
EG - Egitto 18
DZ - Algeria 17
PE - Perù 17
TN - Tunisia 17
PY - Paraguay 16
CH - Svizzera 15
ET - Etiopia 15
CR - Costa Rica 13
EE - Estonia 13
KE - Kenya 13
JM - Giamaica 12
KZ - Kazakistan 12
LV - Lettonia 12
PT - Portogallo 12
TW - Taiwan 12
UY - Uruguay 12
AU - Australia 11
CZ - Repubblica Ceca 11
AL - Albania 10
BO - Bolivia 10
GT - Guatemala 10
NG - Nigeria 10
AZ - Azerbaigian 9
DK - Danimarca 9
DO - Repubblica Dominicana 9
HN - Honduras 9
OM - Oman 9
IE - Irlanda 8
KW - Kuwait 8
BF - Burkina Faso 7
MD - Moldavia 7
NI - Nicaragua 7
BG - Bulgaria 6
GR - Grecia 6
KG - Kirghizistan 6
PA - Panama 6
SN - Senegal 5
AM - Armenia 4
BY - Bielorussia 4
CI - Costa d'Avorio 4
GE - Georgia 4
HR - Croazia 4
HU - Ungheria 4
SK - Slovacchia (Repubblica Slovacca) 4
TT - Trinidad e Tobago 4
AO - Angola 3
BB - Barbados 3
BH - Bahrain 3
CU - Cuba 3
LB - Libano 3
LK - Sri Lanka 3
MN - Mongolia 3
Totale 38.290
Città #
Singapore 2.438
Ashburn 2.220
Helsinki 2.012
Woodbridge 1.498
Fairfield 1.482
San Jose 1.160
Houston 1.146
Jacksonville 958
Santa Clara 931
Chandler 835
Hong Kong 804
Beijing 796
Ann Arbor 670
Seattle 609
Wilmington 539
Cambridge 496
Ho Chi Minh City 362
Ferrara 349
Dallas 328
Council Bluffs 324
Izmir 311
New York 294
Los Angeles 293
Tokyo 280
Nanjing 257
Munich 248
Hanoi 245
Princeton 228
Lauterbourg 200
Boardman 172
Warsaw 151
São Paulo 139
San Diego 127
Milan 117
Shanghai 103
Mexico City 101
London 85
Shenyang 84
Nanchang 82
Chicago 81
Jakarta 81
Buffalo 80
Montreal 72
Orem 72
Hefei 70
Brooklyn 65
Dearborn 63
Chennai 61
Frankfurt am Main 60
Bologna 56
Hebei 55
Jiaxing 55
Changsha 54
Toronto 54
Johannesburg 50
Atlanta 49
Redwood City 49
Vienna 49
Da Nang 47
Moscow 46
Tianjin 45
Haiphong 44
Rio de Janeiro 44
Stockholm 43
Denver 42
Baghdad 41
Rome 41
San Francisco 40
Brussels 39
Turku 39
Poplar 38
Boston 37
Mumbai 37
The Dalles 35
Phoenix 34
Jinan 33
Belo Horizonte 32
Manchester 32
Norwalk 32
Ankara 31
Falkenstein 30
San Mateo 30
Mountain View 28
Falls Church 26
Guangzhou 26
Ningbo 26
Washington 26
Curitiba 24
Addison 23
Naples 22
Tashkent 22
Amsterdam 21
Bengaluru 21
Charlotte 21
Kunming 21
Amman 20
Biên Hòa 20
Bogotá 20
Guayaquil 20
Indiana 20
Totale 25.969
Nome #
Microemulsions of retinoids and pharmaceutical compositions containing them 1.971
Structural studies of lipid based nanosystems for drug delivery: X-Ray Diffraction (XRD) and Cryogenic Transmission Electron Microscopy (cryo-TEM) 414
Biodistribution of nanostructured lipid carriers: a tomographic study 337
Calcitermin-Loaded Smart Gels Activity against Candida albicans: A Preliminary In Vitro Study 331
Effect of new Curcumin-containing nanostructured lipid dispersions on human keratinocytes proliferative responses 307
Cannabinoid antagonist in nanostructured lipid carriers (NLCs): design, characterization and in vivo study 296
Nafion®-containing solid lipid nanoparticles as a tool for anticancer pt delivery: preliminary studies 257
Aminated polysaccharide microspheres as DNA delivery systems 255
Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity 249
Skin care: The innovative nanotechnology to improve the performance of delivery systems 247
Analysis of the drug release profiles from formulations based on micro and nano systems 243
Cationic lipid nanosystems as carriers for nucleic acids 238
Nanostructured lipid carriers (NLC) for the delivery of natural molecules with antimicrobial activity: production, characterisation and in vitro studies 238
Cationic lipospheres as delivery systems for nucleic acid molecules 237
Acrylic microspheres for oral controlled release of the biguanide buformin 237
Acyclovir delivery systems 235
Nuove strategie per la veicolazione di acidi nucleici: nanosistemi cationici a matrice lipidica 234
Characterization Methods for Nanoparticle–Skin Interactions: An Overview 232
Cubosome dispersions as delivery systems for percutaneous administration of indomethacin 231
Amphiphilic association systems for amphotericin B delivery 230
Design and characterization of ethosomes for transdermal delivery of caffeic acid 228
Design of Nanosystems for the Delivery of Quorum Sensing Inhibitors: A Preliminary Study 227
Cellulose acetate butyrate microcapsules containing dextran ion-exchange resins as self-propelled drug release system 223
Biodegradable microparticles for sustained delivery of tetracycline to the periodontal pocket: Formulatory and drug release studies 222
Clotrimazole Nanoparticle gel for mucosal administration. 222
Progesterone lipid nanoparticles: Scaling up and in vivo human study 221
Lipid-based nanoparticles containing cationic derivatives of PTA (1,3,5-triaza-7-phosphaadamantane) as innovative vehicle for Pt complexes: production, characterization and in vitro studies 220
Data on scaling up and in vivo human study of progesterone lipid nanoparticles 220
In situ forming gels as subcutaneous delivery systems of curcumin and piperine 219
Amphiphilic association systems for Amphotericin B delivery 218
Ursodeoxycholic acid for oral administration: a formulatory study of a suspension. 217
Production of lipospheres as carriers for bioactive compounds 211
Monoolein Aqueous Dispersions as a delivery system for quercetin 211
Nanostructured lipid systems modified with waste material of propolis for wound healing: design, in vitro and in vivo evaluation 211
Non-phospholipid vesicles as carriers for peptides and proteins: production, characterization and stability studies 209
L-dopa co-drugs in nanostructured lipid carriers: a comparative study 208
Ethosomes and organogels for cutaneous administration of crocin 207
Budesonide microparticles for the treatment of Crohn's disease 205
Nanoformulations for dimethyl fumarate: Physicochemical characterization and in vitro/in vivo behavior 205
Liposomes as carriers for DNA-PNA hybrids 203
"Plurethosome" as vesicular system for cutaneous administration of mangiferin: formulative study and 3D skin tissue evaluation 203
Cationic liposomes as carriers for ocular administration of anti herpetic peptides 202
Design and characterization of fenretinide containing organogels 202
Microparticles as delivery systems for local delivery to the oral cavity. 201
Nanoparticulate lipid dispersions for bromocriptine delivery: characterization and in vivo study 201
Challenges in the physical characterization of lipid nanoparticles 201
Solid lipid nanoparticles for the delivery of 1,3,5-triaza-7-phosphaadamantane (PTA) platinum (ii) carboxylates 200
Encapsulation of cannabinoid drugs in nanostructured lipid carriers 200
Cationic lipid nanosystems as carriers for nucleic acids 200
Formulation study for the antitumor drug camptothecin: liposomes, micellar solutions and a microemulsion 199
Nanostructured lipid dispersions for topical administration of crocin, a potent antioxidant from saffron (Crocus sativus L.) 199
Gelified reverse micellar dispersions as percutaneous formulations 198
Gallic acid loaded poloxamer gel as new adjuvant strategy for melanoma: A preliminary study 197
A correlative imaging study of in vivo and ex vivo biodistribution of solid lipid nanoparticles 197
Influence of formulation and process parameters on pellet production by powder layering technique 196
Nanosistemi lipidici per la veicolazione di acidi nucleici 196
Microparticles containing gallic and ellagic acids for the biological control of bacterial diseases of kiwifruit plants 196
Lipid nanocarriers containing a Levodopa prodrug with potential antiparkinsonian activity 196
Active substance controlled release device for sanitization of spaces susceptible of containing degenerative organic material 195
Comparative analysis of tetracycline-containing dental gels: poloxamer- and monoglyceride-based formulations 191
Effects of phospholipid based formulations on in vitro and in vivo percutaneous absorption of methyl nicotinate 189
Polymeric microparticles for fenretinide administration 189
Nanostructured lipid carriers as delivery systems for parkinson’s therapy 186
Ethosomes and liposomes as topical vehicles for azelaic acid: A preformulation study 186
Effect of nanostructured lipid vehicles on percutaneous absorption of curcumin 186
Clotrimazole-loaded nanostructured lipid carrier hydrogels: thermal analysis and in vitro studies 186
Intranasal immunization in mice with non-ionic surfactants vesicles containing HSV immunogens: a preliminary study as possible vaccine against genital herpes 186
Preparation of liposomes by reverse-phase evaporation using alternative organic solvents 185
Eudragit® microparticles for the release of budesonide: A comparative study 185
Kinetics of bromocriptine release from microspheres: Comparative analysis between different in vitro models 183
Ethosomes and transethosomes for mangiferin transdermal delivery 183
Nanosystems for skin hydration: a comparative study 182
Curcumin containing monoolein aqueous dispersions: a preformulative study 181
Lipid nanoparticles for administration of poorly water soluble neuroactive drugs 181
Cationic nanostructured lipid carrier (NLC) and monoolein aqueous dispersions (MAD) as potential carriers for nucleic acids 180
Cationic liposomes carrying anti herpetic peptides as potential ocular vaccine 180
Microfluidic Fabricated Liposomes for Nutlin-3a Ocular Delivery as Potential Candidate for Proliferative Vitreoretinal Diseases Treatment 179
Liposome-associated retinoids: production, characterization and antiproliferative activity on neoplastic cells 179
Long-chain cationic derivatives of PTA (1,3,5-triaza-7-phosphaadamantane) as new components of potential non-viral vectors 179
Dimethyl Fumarate-Loaded Transethosomes: A Formulative Study and Preliminary Ex Vivo and In Vivo Evaluation 178
Enhanced Anti-Melanoma Activity of Nutlin-3a Delivered via Ethosomes: Targeting p53-Mediated Apoptosis in HT144 Cells 177
Ethosomal Gel for Topical Administration of Dimethyl Fumarate in the Treatment of HSV-1 Infections 177
Gelatin microspheres: Influence of preparation parameters and thermal treatment on chemico-physical and biopharmaceutical properties 177
In vitro cytotoxic activity of some glucosinolate-derived products generated by myrosinase hydrolysis 177
Effect of cationic liposome composition on in vitro cytotoxicity and protective effect on carried DNA 176
Effect of DNA complexation and freeze-drying on the physicochemical characteristics of cationic liposomes 174
Cationic phosphines for the obtaining of non-viral vectors 174
Lipid-based supramolecular systems for topical application: A preformulatory study 174
Comparative study on the release kinetics of methyl-nicotinate from topic formulations 173
The potential of caffeic acid lipid nanoparticulate systems for skin application: in vitro assays to assess delivery and antioxidant effect 173
Properties and applications of liposomes in cosmetics 171
Effect of charge and lipid concentration on in-vivo percutaneous absorption of methyl nicotinate from liposomal vesicles 171
Pharmaceutical and biotechnological applications of multiple emulsions 170
Myrosinase-generated isothiocyanate from glucosinolates: Isolation, characterization and in vitro antiproliferative studies 170
Rheologic and NMR characterization of monoglyceride-based formulations 168
Production, physico-chemical characterization and biodistribution studies of lipid nanoparticles 168
GELATIN MICROSPHERES AS A NEW APPROACH FOR THE CONTROLLED DELIVERY OF SYNTHETIC OLIGONUCLEOTIDES AND PCR-GENERATED DNA FRAGMENTS 168
Ethosomes for Curcumin and Piperine Cutaneous Delivery to Prevent Environmental-StressorInduced Skin Damage 167
Production of lipospheres for bioactive compounds delivery 167
Eudragit® /Pluronic nanoparticles as mucosal delivery system for peptides and proteins: an in vitro study 167
Totale 22.398
Categoria #
all - tutte 171.151
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 8.148
Totale 179.299


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.932 0 248 148 124 56 101 116 135 71 185 185 563
2022/20232.079 239 64 70 232 344 351 66 205 269 16 144 79
2023/20241.178 134 116 53 31 85 230 70 77 23 42 61 256
2024/20255.286 148 122 391 177 708 521 185 392 933 477 764 468
2025/202615.968 1.313 659 1.257 1.805 1.895 870 1.552 880 3.186 1.628 607 316
2026/2027826 395 431 0 0 0 0 0 0 0 0 0 0
Totale 38.723